NCT06771843

Brief Summary

The investigators developed the Kisoboka ("It is possible") Intervention to address limitations of existing evidence-based interventions to optimize treatment as prevention among men living with HIV who drink alcohol at hazardous levels in "risk environments" such as fishing communities through reductions in hazardous alcohol use, improved adherence to HIV medications and achieving undetectable HIV viral loads. Social and structural determinants unique to fishing communities interact to create a risk environment where hazardous drinking impedes adherence to HIV medications among men living with HIV, including prevalent social norms of drinking, drinking as a way of experiencing "reward" and connecting with others (e.g. in the context of transactional sex), stressful work conditions, a "live for today" outlook, and a cash-based economy with no traditional savings infrastructure leading to ease of daily expenditure on drinking and sex work. These social and environmental conditions result in high levels of alcohol misuse and HIV risk, poor HIV outcomes, and exacerbation of HIV-associated wellness comorbidities such as poor mental and subjective physical health and food insecurity. The goal of this study is to learn if the intervention called Kisoboka works to help men in fishing communities reduce hazardous alcohol use, be better able to take the participants HIV medication as prescribed, and have undetectable HIV viral loads. The investigators will compare the Kisoboka intervention to a brief alcohol screening, adherence counseling, and referrals, and to components of the Kisoboka intervention. Participants will attend intervention counseling sessions according to the study arm to which the participants are randomly assigned. The number of sessions ranges from 1 to 6 over 1 to 16 weeks and are individual only or both individual and group sessions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
716

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Jun 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Jun 2025Feb 2029

First Submitted

Initial submission to the registry

January 9, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 13, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

June 16, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

June 17, 2025

Status Verified

June 1, 2025

Enrollment Period

3.3 years

First QC Date

January 9, 2025

Last Update Submit

June 16, 2025

Conditions

Keywords

behavioral economicsmotivational interviewing

Outcome Measures

Primary Outcomes (4)

  • Change in Phosphatidylethanol (PEth) From Baseline

    alcohol biomarker which correlates well with the volume of alcohol consumed over the prior 2-4 weeks

    6 and 12 month follow up

  • Number of Participants with very Hazardous Alcohol Use at Baseline, 6, and 12 Month Follow up

    Combined biomarker self-report outcome. Number of participants with phosphatidylethanol values ≥400ng/mL OR AUDIT-C scores ≥9. AUDIT-C is the Alcohol Use Disorder Identification Test - Concise.

    6 and 12 month follow up

  • Number of Participants With Optimal Antiretroviral (ART) Adherence at Baseline, 6 and 12 Month Follow up

    ART levels tested using blood biomarkers with cut points indicating 6 or more doses per week

    6 and 12 month follow up

  • Number of Participants with Undetectable HIV Viral Loads at baseline, 6, and 12 month follow up

    HIV viral load laboratory test results showing undetectable viral load per the assay used (e.g., \<20, \<40 copies/ml)

    6 and 12 month follow up

Secondary Outcomes (4)

  • Change in depressive symptoms from baseline

    6 and 12 month follow up

  • Number of participants with optimal self-reported Antiretroviral Adherence at Baseline, 6 and 12 months

    6 and 12 month follow up

  • Change in subjective physical health from baseline

    6 and 12 month follow up

  • Number of participants who are food secure at baseline, 6 months, and 12 months

    6 and 12 month follow up

Other Outcomes (4)

  • Change in delayed reward discounting from baseline

    6 and 12 month follow up

  • Change in endorsement of alternative reinforcers from baseline

    6 and 12 month follow up

  • Change from baseline in endorsement of the reward value of alcohol

    6 and 12 month follow up

  • +1 more other outcomes

Study Arms (4)

Kisoboka (BE + MI and synergy)

EXPERIMENTAL
Behavioral: Kisoboka

Behavioral Economics (BE)

EXPERIMENTAL
Behavioral: Behavioral Economics

Motivational Interviewing (MI)

EXPERIMENTAL
Behavioral: Motivational Interviewing

Screening and Referral (S&R)

ACTIVE COMPARATOR
Behavioral: Screening and Referral

Interventions

KisobokaBEHAVIORAL

Intervention activities: Financial goal setting (developing delayed rewards), Text message reminders of savings goals (increase salience of delayed rewards), Substance-free activities (alternative reinforcers), Mobile money savings and work payments (constraints on buying alcohol), Social support \& role models for financial goals and substance-free activities (delayed rewards, alternative reinforcers), Financial literacy, Develop motivation \& confidence for change, Goal setting for alcohol reduction \& ART adherence, Alcohol harms \& defining low risk drinking Discuss challenges to change and maintain alcohol risk reduction and improved adherence, Developing \& reinforcing discrepancy between savings/life goals and drinking/poor adherence, Developing discrepancy activity: goals for savings and healthy living and weekly, monthly, yearly spending on alcohol Self-monitoring of savings \& spending Text message reminders to reinforce discrepancy between unhealthy behavior \& goals

Kisoboka (BE + MI and synergy)

Intervention activities: Financial goal setting (developing delayed rewards), Text message reminders of savings goals (increase salience of delayed rewards), Substance free activities (alternative reinforcers), Mobile money savings and work payments (constraints on buying alcohol/ decrease reward value of alcohol), Social support \& role models for financial goals and substance free activities (delayed rewards, alternative reinforcers), Financial literacy

Behavioral Economics (BE)

Intervention activities: Develop motivation and confidence for change, Specific goal setting for alcohol reduction and ART adherence, Alcohol harms \& defining low risk drinking, Discuss challenges to change and to maintain alcohol risk reduction and improved adherence/care engagement

Motivational Interviewing (MI)

Brief feedback on their Alcohol Use Disorders Identification Test (AUDIT) score per the AUDIT brief intervention manual, a referral for alcohol counseling, and brief guidance on the importance of HIV care engagement and adherence following the Ugandan Ministry of Health protocol. A referral coupon with details of the clinic name and location will be provided to each participant and participants will be asked to submit the referral note to the "alcohol and/or HIV counselor".

Screening and Referral (S&R)

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • living with HIV;
  • residing in a fishing community (on most days/nights);
  • AUDIT-C positive (≥4) indicating potential hazardous drinking;
  • \>6 months since initial antiretroviral treatment (ART) initiation;
  • not planning to move from the area within the next 6 months;
  • have their own mobile phone and can be reached via phone.
  • an indicator of potential suboptimal treatment as prevention (TasP) either:
  • (i) last HIV viral load test (within 6 months) was detectable (\>20) or (ii) last viral load test between 6 and 13 months ago was detectable (\>20) and reports missing ≥2 ART doses in the past 2 weeks or (iii) a lack of viral load test results for the prior 13 months in clinic records and reports missing ≥2 ART doses in the past 2 weeks;

You may not qualify if:

  • visibly intoxicated at enrollment (eligible to enroll when not intoxicated);
  • does not speak Luganda or English;
  • currently receiving a majority of work payments via mobile money/digital payments;
  • participated in the Kisoboka pilot RCT;
  • unable to read basic Luganda or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Makerere University Walter Reed Program

Kampala, Uganda

RECRUITING

MeSH Terms

Conditions

AlcoholismHIV Infections

Interventions

Economics, BehavioralMotivational InterviewingMass ScreeningReferral and Consultation

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

PsychologyBehavioral SciencesBehavioral Disciplines and ActivitiesEconomicsHealth Care Economics and OrganizationsDirective CounselingCounselingMental Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesDiagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health PracticeProfessional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Susan M Kiene, PhD, MPH

    San Diego State University

    PRINCIPAL INVESTIGATOR
  • Joseph KB Matovu, PhD, MHS

    Makerere University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joseph Matovu, PhD, MHS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: The study design is a 2x2 factorial randomized controlled trial (RCT); however, the investigators hypothesize an interaction between behavioral economics (BE) and motivational interviewing (MI), and therefore power the study to detect this interaction within the factorial design. With a statistically significant interaction between BE and MI the data would be analyzed as a 4-arm trial. Without a significant nor meaningful interaction the investigators would have additional power to examine effects for BE and MI vs S\&R via a traditional factorial analysis. While a factorial design is often used when no interaction between interventions is expected, it is also especially useful to evaluate a hypothesized interaction.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 13, 2025

Study Start

June 16, 2025

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

February 1, 2029

Last Updated

June 17, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The investigators will share raw questionnaire data. For all data, all identifiable information will be removed and maintained in a secure file for future contact purposes, but Global Unique Identifiers (GUIDs) or pseudoGUIDs will be assigned through the National Institute of Mental Health (NIMH) Data Archive. All other de-identified scientific data (questionnaire datasets, results from biological specimens testing, will be both preserved and shared through NIAAA Data Archive repository. Study protocol for the randomized controlled trial and survey questionnaires will be made available through NIAAA Data Archive repository. This documentation will be provided in portable document format (PDF). Scientific data will be processed and analyzed in standard statistical analysis software (e.g., SPSS, MPLUS, SAS, and R).

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Baseline data, such as demographics and self-reported data, that require no additional analyses will be submitted to the NIAAA Data Archive repository within 4 months after enrollment. Baseline laboratory test data will be added as it becomes available. After the study is complete and unmasked, the study team will submit all remaining data (follow-up data). Data will be shared with the general research community at the time of an associated publication, or the end of the award/support period, whichever comes first. As required by NIAAA Data Archive repository, for each publication developed, the investigators will also create studies that contain the data used in that analysis and include the digital object identifiers (DOI) for that study (from NIAAA Data Archive repository) in the manuscript to aid in findability. NIAAA Data Archive repository makes determinations regarding how long to preserve the data; to date files have been preserved in perpetuity.
Access Criteria
Data will be findable for the research community through the NIMH Data Archive (NIAAA Data Archive specifically) which is established at the time of study funding. For all publications, an NIAAA Data Archive study will be created. Each of those studies is assigned a digital object identifier (DOI). This data DOI will be referenced in the publication. Investigators at institutions with a Federal Wide Assurance (FWA) will be able to gain access to NIAAA Data Archive repository data by submitting a data access request in accordance with applicable NIAAA Data Archive repository policies. Data requests will be reviewed and granted by an NIMH/NIAAA Data Archive Data Access Committee.
More information

Locations